India has granted homegrown drugmaker Biological E permission to begin midstage studies of its Covid-19 vaccine in children and adolescents, according to an official statement quoted by Reuters.
The Drugs Controller General of India (DCGI) gave the approval to the Hyderabad-based pharmaceutical company on September 1, the statement said.
The company will study the safety and tolerability of its vaccine, Corbevax, in this population, it added.
Dear visitor, the comments section is undergoing an overhaul and will return soon.